Aptorum Group Limited (APM)
NASDAQ: APM · IEX Real-Time Price · USD
3.440
+0.120 (3.61%)
Jul 22, 2024, 9:36 AM EDT - Market open
Aptorum Group Employees
Aptorum Group had 3 employees as of December 31, 2023. The number of employees decreased by 16 or -84.21% compared to the previous year.
Employees
3
Change (1Y)
-16
Growth (1Y)
-84.21%
Revenue / Employee
$143,793
Profits / Employee
-$941,549
Market Cap
17.85M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
VBI Vaccines | 138 |
Lyra Therapeutics | 88 |
Kindly MD | 65 |
Biotricity | 55 |
Sensei Biotherapeutics | 28 |
Microbot Medical | 22 |
Aeterna Zentaris | 12 |
Indaptus Therapeutics | 7 |
APM News
- 2 months ago - Aptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business Update - Business Wire
- 4 months ago - Aptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy Business - Business Wire
- 7 months ago - Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023 - Business Wire
- 7 months ago - Aptorum Group Limited Announces Results of 2023 Annual General Meeting of Shareholders - Business Wire
- 8 months ago - Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023 - Business Wire
- 1 year ago - Aptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital Markets - Business Wire
- 1 year ago - Aptorum Group Updates on a Phase 1b/2a Clinical Trial for Repurposed Small Molecule Drug SACT-1 for Neuroblastoma - Business Wire
- 1 year ago - Aptorum Group Limited Announces Voluntary Delisting from Euronext Paris - Business Wire